Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Global Fetal Bovine Serum Market Size Study & Forecast, By Application (Drug Discovery, In-vitro Fertilization, Vaccine Production, Cell-based Research, Diagnostics, Others), By End-user (Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CRO), Academic and Research Organizations, Others), and Regional Analysis, 2023-2030
... Others), and Regional Analysis, 2023-2030 Global Fetal Bovine Serum Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the ... Read More
-
2024 Global Forecast for Pancreatic Cancer Therapeutics And Diagnostics Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... 50 countries. The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD ... Read More
-
2024 Global Forecast for Erectile Dysfunction Drugs (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
Global Transcriptomics Market Size Study & Forecast, By Type (Consumables, Instruments, Software, Services) By Technology (Microarrays, q PCR, Sequencing Technology) By Application (Drug Discovery, Diagnostics and Disease Profiling, Others) and Regional Analysis, 2023-2030
... Market is valued at approximately USD 6633.20 million in 2022 and is anticipated to grow with a healthy growth rate of more than 7% over the forecast period 2023-2030. Transcriptomics is a branch of molecular ... Read More
-
2024 Global Forecast for Plasma Therapeutics Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
2024 Global Forecast for Plasma Protein Therapeutics Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More
-
Global RNAi Therapeutics Market (by Molecule Type, Application, End-User & Region): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)
... 2028, progressing at a CAGR of 10.02%, over the period 2024-2028. Factors such as rising utilization in oncology pharmaceuticals, accelerating growth rates of infectious diseases, enlarging geriatric population, increasing prevalence of neurodegenerative disorders and progress ... Read More
-
Global Immunomodulators Databank Market Report
... segment is expected to be the highest contributor to this market, with $78,020.3 Million in 2020, and is anticipated to reach $151,171.1 Million by 2029, registering a CAGR of 7.67%. Oncology and Respiratory segments collectively ... Read More
-
Global Multiple Myeloma Therapeutics Databank Market Report
... 2021 to 2029. Medication segment is expected to be the highest contributor to this market, with $8,265.9 Million in 2020, and is anticipated to reach $14,610.5 Million by 2029, registering a CAGR of 6.57%. Medication ... Read More
-
Global Drug Screening Databank Market Report
... 2031. Drug Screening Service segment is expected to be the highest contributor to this market, with $2,091.3 Million in 2022, and is anticipated to reach $5,840.6 Million by 2031, registering a CAGR of 12.15%. Drug ... Read More
-
Global Food Allergy Diagnostics & Therapeutics Databank Market Report
... CAGR of 6.03% from 2023 to 2031. Diagnostic Products segment is expected to be the highest contributor to this market, with $2,241.8 Million in 2022, and is anticipated to reach $3,594.6 Million by 2031, registering ... Read More
-
Global Attention Deficit Hyperactivity Disorder Databank Market Report
... 7.15% from 2021 to 2029. Stimulants segment is expected to be the highest contributor to this market, with $350.6 Million in 2020, and is anticipated to reach $669.0 Million by 2029, registering a CAGR of ... Read More
-
Global Scleroderma Therapeutics Databank Market Report
... 2031. Immunosuppressors segment is expected to be the highest contributor to this market, with $1,235.9 Million in 2022, and is anticipated to reach $1,832.6 Million by 2031, registering a CAGR of 4.52%. Prostacyclin Analogues segment ... Read More
-
Global Viral Conjunctivitis Pipeline Drugs Databank Market Report
... 3.20% from 2023 to 2031. DST-100 segment is expected to be the highest contributor to this market, with $2,017.3 Million in 2022, and is anticipated to reach $2,548.2 Million by 2031, registering a CAGR of ... Read More
-
Global Ophthalmology Drugs Databank Market Report
... 2031. Anti-VEGF Agents segment is expected to be the highest contributor to this market, with $14,005.3 Million in 2022, and is anticipated to reach $23,509.4 Million by 2031, registering a CAGR of 5.97%. Antiallergy segment ... Read More
-
Global Drugs for Malaria Market Size, Manufacturers, Opportunities and Forecast to 2030
... in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria ... Read More
-
Global Investigational Drug CDMO Databank Market Report.pdf
... from 2023 to 2031. Sclerotherapy segment is expected to be the highest contributor to this market, with $1,010.7 Million in 2022, and is anticipated to reach $1,616.5 Million by 2031, registering a CAGR of 5.40%. ... Read More
-
Drugs for Malaria Industry Research Report 2024
... temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by ... Read More
-
Recombinant Dna Technology Market, By Product Type (Recombinant Protein Drugs, Vaccines , Genetically Modified Crops, Cell and Gene Therapy, and Gene Editing), By Application (Therapeutics, Agriculture, Research, and Others), By End User (Biotechnology and Pharmaceutical Company, Diagnostic Laboratories, Academic and Government Institutes, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Company, Diagnostic Laboratories, Academic and Government Institutes, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Recombinant DNA technology is the joining together of DNA molecules from two different ... Read More
-
Global Acute Myeloid Leukemia Therapeutics Databank Market Report
... 5.19% from 2023 to 2031. Targeted Therapy and Immunotherapy segment is expected to be the highest contributor to this market, with $5,909.9 Million in 2022, and is anticipated to reach $8,938.5 Million by 2031, registering ... Read More
-
Global Insomnia Therapeutics Databank Market Report
... 2031. Drugs segment is expected to be the highest contributor to this market, with $3,103.4 Million in 2022, and is anticipated to reach $4,664.6 Million by 2031, registering a CAGR of 4.67%. Medical Devices segment ... Read More
-
Global Multiple Sclerosis Therapeutics Databank Market Report
... 2021 to 2029. Small-molecule Drugs segment is expected to be the highest contributor to this market, with $6,472.6 Million in 2020, and is anticipated to reach $12,240.1 Million by 2029, registering a CAGR of 7.38%. ... Read More
-
Global Myelodysplastic Syndrome Drugs Databank Market Report
... 2023 to 2031. Immunomodulatory Drugs segment is expected to be the highest contributor to this market, with $982.9 Million in 2022, and is anticipated to reach $2,003.9 Million by 2031, registering a CAGR of 8.28%. ... Read More
-
Global Investigational Drug CDMO Databank Market Report
... 2023 to 2031. Small Molecule segment is expected to be the highest contributor to this market, with $3,991.1 Million in 2022, and is anticipated to reach $6,166.8 Million by 2031, registering a CAGR of 5.00%. ... Read More
-
Global Liver Cancer Drugs Databank Market Report
... 2023 to 2031. Targeted Therapy segment is expected to be the highest contributor to this market, with $1,442.5 Million in 2022, and is anticipated to reach $4,029.6 Million by 2031, registering a CAGR of 12.16%. ... Read More
Research Assistance
